Shilpa Medicare gets USFDA nod for cancer treatment injection

Shares of Shilpa Medicare were trading 3.80 per cent up at Rs 398.65 apiece on BSE.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2SvX9PB
via IFTTT